The Hydration Pharmaceuticals Company Ltd (HPC) - Net Assets
Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has net assets worth AU$2.71 Million AUD (≈ $1.92 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$3.93 Million ≈ $2.78 Million USD) and total liabilities (AU$1.22 Million ≈ $866.72K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check The Hydration Pharmaceuticals Company Lt (HPC) tangible net worth to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$2.71 Million |
| % of Total Assets | 68.85% |
| Annual Growth Rate | 0.49% |
| 5-Year Change | 36.91% |
| 10-Year Change | N/A |
| Growth Volatility | 247.36 |
The Hydration Pharmaceuticals Company Ltd - Net Assets Trend (2018–2024)
This chart illustrates how The Hydration Pharmaceuticals Company Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of The Hydration Pharmaceuticals Company Lt to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for The Hydration Pharmaceuticals Company Ltd (2018–2024)
The table below shows the annual net assets of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. For live valuation and market cap data, see The Hydration Pharmaceuticals Company Lt market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$2.74 Million ≈ $1.94 Million |
+865.40% |
| 2023-12-31 | AU$-358.25K ≈ $-253.49K |
-109.00% |
| 2022-12-31 | AU$3.98 Million ≈ $2.82 Million |
-69.90% |
| 2021-12-31 | AU$13.23 Million ≈ $9.36 Million |
+560.38% |
| 2020-12-31 | AU$2.00 Million ≈ $1.42 Million |
-18.06% |
| 2019-12-31 | AU$2.44 Million ≈ $1.73 Million |
-8.20% |
| 2018-12-31 | AU$2.66 Million ≈ $1.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to The Hydration Pharmaceuticals Company Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2917148600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$39.67 Million | 1446.81% |
| Other Comprehensive Income | AU$3.48 Million | 126.91% |
| Total Equity | AU$2.74 Million | 100.00% |
The Hydration Pharmaceuticals Company Ltd Competitors by Market Cap
The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Diamcor Mining
V:DMI
|
$1.22 Million |
|
Gossan Resources Ltd
V:GSS
|
$1.22 Million |
|
Value Management & Research AG
F:VMR1
|
$1.22 Million |
|
Asia Pacific Investama Tbk PT
JK:MYTX
|
$1.22 Million |
|
Team Internet Group PLC
LSE:TIG
|
$1.22 Million |
|
Mpower Group Ltd
AU:MPR
|
$1.22 Million |
|
Jaxon Mining Inc
V:JAX
|
$1.22 Million |
|
EDESAL Holding SA
BA:EDLH
|
$1.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The Hydration Pharmaceuticals Company Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -358,255 to 2,742,091, a change of 3,100,346.
- Net income of 2,667,533 contributed positively to equity growth.
- Share repurchases of 23,969 reduced equity.
- Other comprehensive income increased equity by 88,573.
- Other factors increased equity by 368,209.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$2.67 Million | +97.28% |
| Share Repurchases | AU$23.97K | -0.87% |
| Other Comprehensive Income | AU$88.57K | +3.23% |
| Other Changes | AU$368.21K | +13.43% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares The Hydration Pharmaceuticals Company Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.39x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.09x to 0.39x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | AU$0.05 | AU$0.00 | x |
| 2019-12-31 | AU$0.04 | AU$0.00 | x |
| 2020-12-31 | AU$0.03 | AU$0.00 | x |
| 2021-12-31 | AU$0.18 | AU$0.00 | x |
| 2022-12-31 | AU$0.02 | AU$0.00 | x |
| 2023-12-31 | AU$0.00 | AU$0.00 | x |
| 2024-12-31 | AU$0.01 | AU$0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently The Hydration Pharmaceuticals Company Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 97.28%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 83.23%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.82x
- Recent ROE (97.28%) is above the historical average (-112.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -366.87% | -230.76% | 0.98x | 1.62x | AU$-9.86 Million |
| 2019 | -143.94% | -115.91% | 0.71x | 1.76x | AU$-3.67 Million |
| 2020 | -37.13% | -19.80% | 0.85x | 2.22x | AU$-943.95K |
| 2021 | -67.79% | -146.34% | 0.40x | 1.16x | AU$-10.29 Million |
| 2022 | -266.43% | -116.56% | 0.88x | 2.61x | AU$-11.01 Million |
| 2023 | 0.00% | -80.69% | 1.50x | 0.00x | AU$-8.07 Million |
| 2024 | 97.28% | 83.23% | 0.64x | 1.82x | AU$2.39 Million |
Industry Comparison
This section compares The Hydration Pharmaceuticals Company Ltd's net assets metrics with peer companies in the Food Distribution industry.
Industry Context
- Industry: Food Distribution
- Average net assets among peers: $1,388,600,000
- Average return on equity (ROE) among peers: -10.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| The Hydration Pharmaceuticals Company Ltd (HPC) | AU$2.71 Million | -366.87% | 0.45x | $1.22 Million |
| Metcash Ltd (MTS) | $1.39 Billion | -10.77% | 1.68x | $2.47 Billion |
About The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more